Linagliptin

CAS 668270-12-0

Overview

Linagliptin, sold under the brand name Tradjenta among others, is a medication used to treat diabetes mellitus type 2. It is generally less preferred than metformin and sulfonylureas as an initial treatment. It is used together with exercise and diet. It is not recommended in type 1 diabetes. It is taken by mouth

Anant Labs manufacture and furnish high quality Linagliptin impurities for global markets. Our Linagliptin EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

In Stock

Linagliptin

Cat. No. ANTPRD7388Old No. ANT-LNG-00CAS 668270-12-0In Stock

Technical Data

New Cat. No.ANTPRD7388

Old Cat. No.ANT-LNG-00

CAS668270-12-0

Mol. FormulaC₂₅H₂₈N₈O₂

Mol. Weight472.55 g/mol

IUPAC8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione

SMILESCC#CCN1C2=C(N=C1N3CCC[C@H](C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C

InChIInChI=1S/C25H28N8O2/c1-4-5-13-32-21-22(29-24(32)31-12-8-9-17(26)14-31)30(3)25(35)33(23(21)34)15-20-27-16(2)18-10-6-7-11-19(18)28-20/h6-7,10-11,17H,8-9,12-15,26H2,1-3H3/t17-/m1/s1

InChI KeyLTXREWYXXSTFRX-QGZVFWFLSA-N

Synonyms

8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dioneLinagliptin668270-12-0TradjentaBI-1356BI 1356TrazentaTrajentaBI-1356-BSlinagliptine